ROQUEFORT THERAPEUTICS PLC

Regulatory Filings • Dec 31, 2021

National Storage Mechanism | Additional information

RNS Number : 1112X

Roquefort Investments PLC

31 December 2021

31 December 2021

Roquefort Therapeutics plc

("Roquefort Therapeutics" or the "Company")

Change of Company Name

Roquefort Therapeutics (LSE:ROQ), the London listed investment company established to acquire businesses focused on early-stage opportunities in the biotechnology sector, is pleased to announce that the company name of Roquefort Investments plc has changed to Roquefort Therapeutics plc. The Company's ordinary shares will continue to trade under the ticker ROQ, ISIN GB00BMDQ2T15 and SEDOL code BMDQ2T1.               

No action from shareholders is required in relation to the change.

Enquiries:

Roquefort Therapeutics plc
Stephen West (Chairman)	+44 (0)20 3290 9339
Buchanan (Public Relations) Ben Romney / Jamie Hooper / George Beale Optiva Securities Limited (Broker)	+44 (0)20 7466 5000 roq@buchanan.uk.com
Christian Dennis	+44 (0)20 3411 1881

For further information, please visit www.roquefortinvest.com and @roquefortinvest on Twitter.

LEI: ‎254900P4SISIWOR9RH34

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

CANDKKBNFBDDQBN